DSP World Agriculture Fund An open ended fund of fund scheme investing in BlackRock Global Funds – Nutrition Fund |
Jay Kothari
Total work experience of 16 years.
Managing this scheme since March
2013.
Fund of Funds
Oct 19, 2011
MSCI ACWI Net Total Return
Regular Plan | |
Growth: | ₹ 18.5010 |
Direct Plan | |
Growth: | ₹ 18.9573 |
₹ 34 Cr
₹ 35 Cr
Regular Plan : | 2.47% |
Direct Plan : | 2.31% |
(Including TER of 0.71% of the underlying fund) | |
The investors are bearing the recurring expenses of the Fund, in addition to the expenses of the underlying Fund | |
^Total TER is inclusive of the weighted average expenses levied by underlying schemes under regulation 52(6)(a) of SEBI (Mutual Funds) Regulations, 1996. |
9 Yr
Standard Deviation : | 15.28% |
Beta : | 0.87 |
Sharpe Ratio : | 0.11 |
Nil
Data As On October 31, 2020
DSP World Agriculture Fund (FOF) as on September 30, 2020 | % to Net Assets |
BlackRock Global Funds - Nutrition Fund (Class I2 USD Shares)^^ | 95.77 |
TREPS / Reverse Repo Investments / Corporate Debt Repo | 4.41 |
Net Receivables/Payables | -0.18 |
TOTAL | 100.00 |
BlackRock Global Funds - Nutrition Fun (Underlying Fund) as on September 30, 2020 | |
Top 10 stocks | |
Security | % to Net Assets |
FMC CORPORATION | 4.2 |
NESTLE SA | 4.1 |
KONINKLIJKE DSM NV | 4.0 |
TRACTOR SUPPLY COMPANY | 4.0 |
GROCERY OUTLET HOLDING CORP | 3.9 |
GRAPHIC PACKAGING HOLDING CO | 3.8 |
KERRY GROUP PLC | 3.8 |
JAMIESON WELLNESS INC | 3.7 |
SYMRISE AG | 3.6 |
RESTAURANT BRANDS INTERNATIONAL INC | 3.5 |
OTHERS | 57.2 |
Cash | 4.1 |
Total | 100.00 |
Sector Allocation | |
Ingredients | 14.3 |
Nutritech | 10.0 |
Dieting & Wellness | 7.8 |
Ag Chemical | 7.2 |
Machinery | 6.2 |
Food Producer | 6.1 |
Food Retailer | 5.9 |
Food Distributor | 5.0 |
EM Food Producer | 2.7 |
Fertiliser | 2.2 |
Commodity Processor | 1.0 |
Cannabis | 0.0 |
Other | 27.4 |
Total | 95.88 |
Market Cap Allocation | |
Large (>$10bn) | 43.6 |
Mid | 46.7 |
Small (<$1bn) | 9.7 |
Total | 100.00 |
as on 30th Oct'20
^^Fund domiciled in Luxembourg
Name of Instrument | % to Net Assets |
OTHERS | |
Foreign Securities | |
BlackRock Global Funds - Nutrition Fund (Class I2 USD Shares)^^ | 95.73 |
Total | 95.73 |
MONEY MARKET INSTRUMENTS | |
TREPS / Reverse Repo Investments / Corporate Debt Repo | 4.39 |
Total | 4.39 |
Cash & Cash Equivalent | |
Net Receivables/Payables | -0.12 |
Total | -0.12 |
GRAND TOTAL | 100.00 |
as on 30th Oct'20
^^Fund domiciled in Luxembourg.
Growth of Rs. 1 L invested at inception: | 1.85 L |
SIP Returns(In %) | ||||
5 yr | 3 yr | SI* | ||
6.88 | 7.99 | 5.50 |
Outperformed Benchmark TRI (calendar year) | MSCI ACWI Net Total Return 4% |
5 yr | 3 yr | 1 yr | |
Minimum (%) | -1.5 | -3.4 | -14.7 |
Maximum (%) | 8.5 | 14.7 | 28.3 |
Average (%) | 4.0 | 4.4 | 6.0 |
% times negative returns | 1.8 | 7.8 | 22.0 |
% of times returns are in excess of 7% | 9.0 | 20.2 | 44.8 |
The primary investment objective
of the Scheme is to seek capital
appreciation by investing
predominantly in the units of
BlackRock Global Funds – Nutrition
Fund (BGF – NF). The
Scheme may, at the discretion of the
Investment Manager, also invest in the
units of other similar overseas mutual
fund schemes, which may constitute
a significant part of its corpus. The
Scheme may also invest a certain
portion of its corpus in money market
securities and/or money market/
liquid schemes of DSP Mutual Fund, in
order to meet liquidity requirements
from time to time. However, there
is no assurance that the investment
objective of the Scheme will be
realised. It shall be
noted ‘similar overseas mutual fund
schemes’ shall have investment
objective, investment strategy and
risk profile/consideration similar to
those of BGF – NF.
There is no assurance that the
investment objective of the Scheme
will be realized.
This Open Ended Fund of Funds Scheme is suitable for investors who are seeking*
• Long-term capital growth
• Investment in units of overseas funds which invest primarily in equity and equity related securities of
companies in the agriculture value chain
* Investors should consult their financial advisors if in doubt whether the product is suitable for them.